11 Results for "

LHRH receptors

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "LHRH receptors" in MCE Product Catalog:

Cat. No.: HY-100209
CAS No.: 308831-61-0
Purity:  ≥98.0%
Synonyms: TAK-013
Target:  

GnRH Receptor

Research Areas:  

Endocrinology

Sufugolix (TAK-013) is a highly potent and orally available luteinizing hormone-releasing hormone (LHRH) receptor antagonist with an IC50 of 0.1 nM.
loading...
    loading...
Cat. No.: HY-P3668
CAS No.: 52671-12-2
Target:  

GnRH Receptor

Research Areas:  

Endocrinology Cancer

[D-Lys6]-LH-RH is a Luteinizing-hormone-releasing hormone (LHRH) analogue. [D-Lys6]-LH-RH acts as a GnRH receptor agonist .
loading...
    loading...
Cat. No.: HY-16532
CAS No.: 139570-93-7
Synonyms: AEZS-108; AN-152
Research Areas:  

Cancer

Zoptarelin doxorubicin (AEZS-108; AN-152) is a hybrid anticancer agent, containing Zoptarelin and Doxorubicin. Zoptarelin doxorubicin has been used to research targeting tumors expressing LHRH receptors. Zoptarelin doxorubicin abolishes tumor progression and induces remarkable apoptosis in vitro .
loading...
    loading...
Cat. No.: HY-P3668A
Target:  

GnRH Receptor

Research Areas:  

Endocrinology Cancer

[D-Lys6]-LH-RH TFA is a Luteinizing-hormone-releasing hormone (LHRH) analogue. [D-Lys6]-LH-RH TFA acts as a GnRH receptor agonist .
loading...
    loading...
Cat. No.: HY-P4144
CAS No.: 1174415-90-7
Synonyms: Phor18-LHRH (338613); EP-100
Target:  

GnRH Receptor

Research Areas:  

Cancer

Onvitrelin ucalontide (Phor18-LHRH (338613); EP-100) is a luteinizing hormone-releasing hormone (LHRH) receptor ligand. Onvitrelin ucalontide binds to functional LHRH receptors on cancer cells and mediates targeted cytotoxicity. Onvitrelin ucalontide reduces tumor volume, weight and the number of viable tumor cells in xenograft models. Onvitrelin ucalontide can be used for the research of breast cancer, ovarian cancer and prostate cancer .
loading...
    loading...
Cat. No.: HY-P3672
CAS No.: 51230-19-4
Target:  

GnRH Receptor

Research Areas:  

Endocrinology

[D-Ala6]-LH-RH is a Luteinizing-hormone-releasing hormone (LHRH) analogue. [D-Ala6]-LH-RH acts as a GnRH receptor agonist .
loading...
    loading...
Cat. No.: HY-P2028
CAS No.: 106881-54-3
Target:  

GnRH Receptor

Research Areas:  

Cancer

BIM 21009 is a LHRH and GnRH receptor antagonist. BIM 21009 inhibits tumor growth .
loading...
    loading...
Cat. No.: HY-P2110
CAS No.: 109458-76-6
Target:  

GnRH Receptor

Research Areas:  

Endocrinology

RS-18286 is a potent luteinizing-hormone (LH)-releasing hormone (LHRH) antagonist. RS-18286 blocks the pituitary LHRH receptor and suppresses pituitary luteinizing-hormone (LH) secretion and reduce serum concentrations of gonadal steroids .
loading...
    loading...
Cat. No.: HY-P3671
CAS No.: 68059-94-9
Target:  

GnRH Receptor

Research Areas:  

Endocrinology

[D-Glp1,D-Phe2,D-Trp3,6]-LH-RH is a Luteinizing-hormone-releasing hormone (LHRH) analogue. [D-Glp1,D-Phe2,D-Trp3,6]-LH-RH acts as a GnRH receptor antagonist .
loading...
    loading...
Cat. No.: HY-107533
CAS No.: 199119-18-1
Target:  

GnRH Receptor

Research Areas:  

Endocrinology

T-98475 (Compound 26d) is a potent, orally active, non-peptide luteinizing hormone-releasing hormone (LHRH) receptor antagonist with an IC50 of 0.2 nM .
loading...
    loading...
Cat. No.: HY-P2446
CAS No.: 83539-08-6
Synonyms: APTAA-LHRH
Target:  

GnRH Receptor

Research Areas:  

Endocrinology

ORG 30276 (APTAA-LHRH) is a potent GnRH antagonist that effectively reduces serum LH and FSH levels in male rats. ORG 30276 significantly decreases unoccupied pituitary GnRH receptors, leading to suppressed gonadotropin secretion. ORG 30276 treatment results in a considerable reduction in mRNA levels of gonadotropin beta-subunits in the pituitary gland. ORG 30276's effects on gonadotropin dynamics can be selectively reversed by the replacement of specific sex steroids, with androgens being particularly effective for the FSH beta-subunit mRNA levels.
loading...
    loading...
  • 1